RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDYOFA NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS

被引：0

作者：

Yazici, Y. ^{[1
]}

McAlindon, T. ^{[2
]}

Gibofsky, A. ^{[3
,4
]}

Lane, N. ^{[5
]}

Clauw, D. ^{[6
]}

Grifman, M.

Swearingen, C. ^{[1
]}

DiFrancesco, A. ^{[1
]}

Tambiah, J. ^{[1
]}

Hochberg, M. ^{[7
]}

机构：

[1] Samumed LLC, San Diego, CA USA

[2] Tufts Med Ctr, Boston, MA 02111 USA

[3] Weill Cornell Med, New York, NY USA

[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA

[5] Univ Calif Davis, Davis, CA 95616 USA

[6] Univ Michigan, Ann Arbor, MI 48109 USA

[7] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

432

引用

页码：S137 / S137

页数：1

共 50 条

[21] A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study
Yazici, Y.
McAlindon, T. E.
Fleischmann, R.
Gibofsky, A.
Lane, N. E.
Kivitz, A. J.
Skrepnik, N.
Armas, E.
Swearingen, C. J.
DiFrancesco, A.
Tambiah, J. R. S.
Hood, J.
Hochberg, M. C.
OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (10) : 1598 - 1606
[22] PROSPECTIVE COMPARISON OF INTRA-ARTICULAR SHAM VS. PLACEBO INJECTIONS: DATA FROM A RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SM04690, A WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
Yazici, Y.
Tambiah, J.
Swearingen, C.
Kennedy, S.
Strand, V.
Cole, B.
Hochberg, M.
Bannuru, R.
McAlindon, T.
OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S519 - S520
[23] Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial
Maurizio Rossini
Silvano Adami
Elena Fracassi
Ombretta Viapiana
Giovanni Orsolini
Maria Rosaria Povino
Luca Idolazzi
Davide Gatti
Rheumatology International, 2015, 35 : 255 - 263
[24] Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial
Rossini, Maurizio
Adami, Silvano
Fracassi, Elena
Viapiana, Ombretta
Orsolini, Giovanni
Povino, Maria Rosaria
Idolazzi, Luca
Gatti, Davide
RHEUMATOLOGY INTERNATIONAL, 2015, 35 (02) : 255 - 263
[25] Discovery of an Intra-Articular Injection Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Treatment for Knee Osteoarthritis
Barroga, Charlene
Hu, Yong
Deshmukh, Vishal
Hood, John
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[26] EFFECTS OF INTRA-ARTICULAR CLODRONATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: RESULTS OF A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED TRIAL
Orsolini, G.
Idolazzi, L.
Rossini, M.
Viapiana, O.
Fracassi, E.
Povino, M.
Risoli, M.
Gatti, D.
Adami, S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 745 - 745
[27] INTRA-ARTICULAR ORGOTEIN THERAPY IN OSTEOARTHRITIS OF THE KNEE - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
LUNDOLESEN, K
MENANDERHUBER, KB
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1983, 33-2 (08): : 1199 - 1203
[28] COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTIONS FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
Yazici, Yusuf
Tambiah, Jeyanesh
Swearingen, Christopher
Kennedy, Sarah
Strand, Vibeke
Cole, Brian
Hochberg, Marc
Bannuru, Raveendhara
Mcalindon, Timothy
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 494 - 494
[29] INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
Simsek, I.
Swearingen, C.
Kennedy, S.
Tambiah, J.
Damatarca, C.
Yazici, Y.
Lane, N.
Hochberg, M.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 117 - 117
[30] Intra-articular injection of a novel Wnt pathway inhibitor, SM04690, upregulates Wnt16 expression and reduces disease progression in temporomandibular joint osteoarthritis
Hua, Bingqiang
Qiu, Jin
Ye, Xiaoping
Liu, Xianwen
BONE, 2022, 158

← 1 2 3 4 5 →